European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.81% to 1,477.39 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking company trivago (TRVG), which rose 3.1% and 2%, respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company TotalEnergies (TTE), which were up 1.9% and 1.8%, respectively.
The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and financial services company Banco Santander (SAN), which fell 7.6% and 3.7%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and telecommunications company Nokia (NOK), which dropped 3.3% and 2.4%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which advanced 4.5% and 4%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and oil and gas company BP (BP), which increased 2.5% and 1.4%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and communications company WPP (WPP), which lost 5.6% and 2.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and financial services company Lloyds Banking Group (LYG), which were down 1.9% and 1.8%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。